Event Date/Time: Oct 14, 2009
End Date/Time: Oct 16, 2009
Research in biologics has become a hot area for many large pharmaceutical companies as expiring patents, a flood of generic drugs and slowing growth in small-molecule drug pipelines have led to decreasing revenues. GTCbio`s Biological Therapeutics Conference on October 14-16, 2009 in San Diego, CA provides its participants with a current look at biologics and projects into its future with discussions regarding developments and challenges in immunogenicity, humanization, drug delivery techniques for biologics, modern vaccine development, antibodies, and novel protein and peptide delivery. Overcoming the issue of the role of biologics in drug discovery and how to improve upon the length of time a drug remains effective in the body, without losing money, will be addressed.
Over 150 leading industrial and academic experts will present at this three-day summit. M3D will offer an in-depth examination of the challenges involved in the dynamic and ever-changing field of drug discovery and development. It will bring researchers, lab directors/managers, and industry executives the critical scientific, technology, and business coverage that they need.
This conference is designed for
- Research & Development Professionals
- Project Managers, Group Leaders and Directors
- Presidents, Vice Presidents, and CEOs
- Manufacturers and Marketers
- Global Project Managers and Strategic Planners
- Business Development and Licensing Executives
- Venture Capitalists and Entrepreneurs
- Academic Researchers and Medical Directors
- Government Representatives
Dedicated networking events have been incorporated to enhance the exchange of information between technology developers and end-users. M3D will provide a great opportunity for companies to expose products and services. Click here to Register. Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact Josette Barba at email@example.com or 626-256-6405 x105 for more information.